DrugPatentWatch Database Preview
CAPTOPRIL Drug Profile
» See Plans and Pricing
Which patents cover Captopril, and when can generic versions of Captopril launch?
Captopril is a drug marketed by Ajanta Pharma Ltd, Annora Pharma, Apothecon, Boscogen, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Mylan, Oxford Pharms, Par Pharm, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt Ltd, Yaopharma Co Ltd, Ivax Sub Teva Pharms, and Vintage Pharms Llc. and is included in thirty NDAs.
The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Captopril
A generic version of CAPTOPRIL was approved as captopril; hydrochlorothiazide by MYLAN on December 29th, 1997.
Summary for CAPTOPRIL
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 30 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 107 |
| Clinical Trials: | 42 |
| Patent Applications: | 3,488 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CAPTOPRIL |
| DailyMed Link: | CAPTOPRIL at DailyMed |
Recent Clinical Trials for CAPTOPRIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of Paraíba | Phase 4 |
| Case Comprehensive Cancer Center | Phase 1/Phase 2 |
| Kafrelsheikh University | Phase 2 |
Pharmacology for CAPTOPRIL
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for CAPTOPRIL
US Patents and Regulatory Information for CAPTOPRIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seton Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 212223-004 | Oct 30, 2019 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Cosette | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074827-001 | Dec 29, 1997 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Hikma Intl Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 074505-001 | Feb 13, 1996 | AB | RX | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | |||
| Dava Pharms Inc | CAPTOPRIL | captopril | TABLET;ORAL | 074423-004 | Feb 13, 1996 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| Watson Labs | CAPTOPRIL | captopril | TABLET;ORAL | 074386-004 | May 23, 1996 | DISCN | No | No | Get Started for $10 | Get Started for $10 | Get Started for $10 | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
